Your browser doesn't support javascript.
Why Fibrinolytic Therapy for ST-Segment-Elevation Myocardial Infarction in the COVID-19 Pandemic Is Not Your New Best Friend.
Kirtane, Ajay J; Bangalore, Sripal.
  • Kirtane AJ; Columbia University Medical Center, NewYork-Presbyterian Hospital, the Cardiovascular Research Foundation, NYU-Langone Medical Center, New York.
  • Bangalore S; Columbia University Medical Center, NewYork-Presbyterian Hospital, the Cardiovascular Research Foundation, NYU-Langone Medical Center, New York.
Circ Cardiovasc Qual Outcomes ; 13(6): e006885, 2020 06.
Article in English | MEDLINE | ID: covidwho-629010

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Thrombolytic Therapy / Coronavirus Infections / ST Elevation Myocardial Infarction / Betacoronavirus Type of study: Observational study Limits: Humans Language: English Journal: Circ Cardiovasc Qual Outcomes Journal subject: Vascular Diseases / Cardiology Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Thrombolytic Therapy / Coronavirus Infections / ST Elevation Myocardial Infarction / Betacoronavirus Type of study: Observational study Limits: Humans Language: English Journal: Circ Cardiovasc Qual Outcomes Journal subject: Vascular Diseases / Cardiology Year: 2020 Document Type: Article